EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access

Catheter‐Based Sacral Nerve Block Versus Pudendal Nerve Block in the Treatment of Pudendal Neuralgia: A Randomized Double‐Blinded Controlled Trial

Kai-Kai Guo, Jing Li, Ying Meng, Long Wang, Shu-Rong Li, Gui-Jun Lu, Jing-Jia Sun iD

European Journal of Pain · 2026-08 · 30 (7)

DOI: 10.1002/ejp.70355 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Pain, online erschienen am 06.08.2026. Verfasst von Kai-Kai Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Medicine, Xuanwu Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Nerve Block, Pudendal Nerve, Pudendal Neuralgia. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pudendal neuralgia (PN) severely impacts quality of life, particularly sitting. Uncertainty exists whether catheter‐based sacral nerve block with daily intermittent bolus (SNB) or pudendal nerve block (PNB) is more effective. This trial compared their efficacy over 6 months.

Methods

A prospective, randomized, double‐blinded trial in China enrolled 90 PN patients. Patients were randomized to CT‐guided catheter‐based PNB near the pudendal nerve or SNB through the third posterior sacral foramen. In both groups, the catheter remained in place for 7 days, and 10 mL of 0.2% ropivacaine was administered once daily as an intermittent bolus, with compound betamethasone administered on Day 7. Primary outcome was pain intensity (VAS) over 6 months; secondary outcomes included patient‐reported global outcomes and maximum sitting time at 6 months.

Results

The SNB group had significantly lower VAS scores at 1 month (2.98 ± 1.47 vs. 3.72 ± 1.08, p = 0.04), 3 months (3.36 ± 1.14 vs. 4.17 ± 1.19, p = 0.02), and 6 months (3.85 ± 1.04 vs. 4.95 ± 1.08, p < 0.0001). Significantly more SNB patients reported excellent/good outcomes at 1 month (83.88% vs. 63.40%, p = 0.04) and 6 months (75.61% vs. 37.50%, p = 0.002). Maximum sitting time at 6 months was longer with SNB (68.56 ± 21.61 vs. 37.65 ± 16.25 min, p < 0.0001). No severe complications occurred.

Conclusions

SNB provided superior and sustained pain relief, functional improvement, and patient satisfaction compared to PNB over 6 months in PN patients. Broader sacral root (S2‐4) coverage by SNB may enhance efficacy by targeting pudendal neuropathy and central sensitization. SNB may be considered as an intermediate minimally invasive option for selected refractory PN patients in experienced centers, pending larger safety and feasibility studies. Significance Statement This first RCT directly comparing catheter‐based nerve blocks for pudendal neuralgia demonstrates that sacral nerve block (SNB targeting S2‐4) provides significantly superior and sustained pain relief, functional gains (doubled sitting tolerance), and patient satisfaction over pudendal nerve block (PNB) at 6 months. Its broader root coverage likely addresses central sensitization alongside neuropathy. Catheter‐based sacral nerve block with daily intermittent bolus may represent an intermediate minimally invasive option for selected patients with refractory PN in experienced centers capable of structured catheter monitoring. Because this trial was not powered to estimate rare infectious complications and required a 7‐day inpatient protocol, larger multicenter studies are needed to define safety, feasibility, cost‐effectiveness, and the potential for outpatient adaptation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nerve BlockPudendal NervePudendal NeuralgiaHumansFemaleDouble-Blind MethodMiddle AgedMaleAgedTreatment OutcomeProspective StudiesAnesthetics, LocalRopivacaineAdultPain Measurement

Stichwörter der Autor:innen

VAS scorespudendal nerve blockpudendal neuralgiasacral 2–4 nerves blocksitting time

Substanzen

Anesthetics, LocalRopivacaine

Autor:innen und Institutionen

  • Department of Pain Medicine, Xuanwu Hospital of Capital Medical University, Beijing, China.
  • Department of Acupuncture and Moxibustion, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Anesthesiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Pain Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Anesthesiology, the First Hospital of Putian City, Putian, Fujian, China.
  • Department of Pain Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

ORCID-Profile: Jing-Jia Sun

Zitieren

APA

Guo, K. K., Li, J., Meng, Y., Wang, L., Li, S. R., Lu, G. J., & Sun, J. J. (2026). Catheter‐Based Sacral Nerve Block Versus Pudendal Nerve Block in the Treatment of Pudendal Neuralgia: A Randomized Double‐Blinded Controlled Trial. European Journal of Pain, 30(7). https://doi.org/10.1002/ejp.70355

Vancouver

Guo KK, Li J, Meng Y, Wang L, Li SR, Lu GJ, et al. Catheter‐Based Sacral Nerve Block Versus Pudendal Nerve Block in the Treatment of Pudendal Neuralgia: A Randomized Double‐Blinded Controlled Trial. European Journal of Pain. 2026;30(7). doi:10.1002/ejp.70355

BibTeX
@article{Guo2026,
  author = {Guo, Kai-Kai and Li, Jing and Meng, Ying and Wang, Long and Li, Shu-Rong and Lu, Gui-Jun and Sun, Jing-Jia},
  title = {Catheter‐Based Sacral Nerve Block Versus Pudendal Nerve Block in the Treatment of Pudendal Neuralgia: A Randomized Double‐Blinded Controlled Trial},
  journal = {European Journal of Pain},
  year = {2026},
  volume = {30},
  number = {7},
  doi = {10.1002/ejp.70355}
}
Kostenlos starten →